MEDITOPE BIOSCIENCES INC has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in Australia, Canada and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are F STAR DELTA LTD, CHECKPOINT THERAPEUTICS INC and GILLIES STEPHEN D.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Republic of Korea | 2 | |
#6 | United States | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Matho Michael H | 14 |
#2 | Gardiner Elisabeth M | 7 |
#3 | Dumitru Calin | 7 |
#4 | Mckenzie Robert P | 7 |
#5 | Gardiner Elisabeth | 7 |
#6 | Dumitru Calin Dan | 6 |
#7 | Dumitru Calin D | 1 |
Publication | Filing date | Title |
---|---|---|
CA3012196A1 | Anti-egfr antibody drug conjugate | |
CN108712908A | It is selfed len antibody |